Welcome to our preliminary website
Orexa BV is a young, life sciences company, originated as a spin-off from Chardon Pharma BV in 2016. It develops proprietary, new pharmacological interventions for the treatment of diseases and medical problems related to human food intake and retention. Orexa's initial focus will be on the development of a proprietary pharmaceutical for increased food intake in Post-operative Ileus and in elderly.
Orexa’s management team consists of the following people:
Jasper Buijs - CEO
Ard Peeters - CSO